Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Addressing A Global Health Priority In Australia And New Zealand
For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
Patient-Focused Strategies For Long-Term Follow-Up In Gene Therapies
As the landscape evolves, sponsors must adopt innovative, patient-centered approaches and technologies to effectively conduct LTFU studies, minimizing the burden on patients and research sites.
The Key To Clinical Trial Success In 2025
As the landscape of clinical trials continues to evolve, point-of-need care and the integration of mobile clinics present a scalable approach to improve retention, compliance, and patient satisfaction.

An Introduction To One Home for Sites™
4/18/2024

This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.
eISF In European Clinical Trials And How eBinders Can Help
1/18/2024

By addressing the unique hurdles tied to regulations in European clinical trials, eBinders offer a streamlined approach to managing electronic trial documentation.
Targeted Protein Degraders: Transforming Oral Therapeutics
8/11/2025

CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
5 Outdated Practices Holding Back Modern Bioanalysis
10/20/2025

Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.
Enhancing Clinical Trial Flexibility
9/1/2025

Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

Even The Most Complex Studies Reach Milestones Faster

Whether it's complex randomization, adaptive trials, Direct-to-Patient models, or recurring visit cycles, discover how Rave RTSM is able to grant your team instant access to the full spectrum of current and forthcoming study features.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Infectious Diseases And Vaccines CRO Services

Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.
How Biorasi Optimizes Clinical Solutions

Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.
Regulatory Strategy And Submission Support

This Regulatory Operations Team enables biotech and pharmaceutical companies to focus on innovation while ensuring a smooth, compliant path to market entry.